>For most biologics, the manufacturer would have requested and got a patent term extension under 35 USC 156. The practical limit seems to be 14 yrs from date of approval. This would be an easy way of looking at upcoming expiry I guess.<
That would work if there were no ancillary patents in play. But it’s the ancillary patents that make life so complicated!